Navigation Links
URL Pharma Launches Colcrys(R) Patient Assistance Program
Date:12/23/2009

PHILADELPHIA, Dec. 23 /PRNewswire/ -- URL Pharma, Inc. today announced the launch of the Colcrys® (colchicine, USP) Patient Assistance Program, an initiative that will allow patients with limited means to save on Colcrys prescriptions. This program reflects URL Pharma's ongoing commitment to helping ensure that all patients who rely on the company's medications are able to access them, regardless of economic status. Colcrys is indicated for the prevention and treatment of gout flares and for the treatment of Familial Mediterranean Fever (FMF).

"URL Pharma believes that patients should not be forced to sacrifice in order to afford their medication, especially in these difficult economic times," said Richard H. Roberts, MD, PhD, President, CEO and Chairman, URL Pharma. "The Colcrys Patient Assistance Program will help ensure that limited income is not a barrier to patients who need Colcrys."

The Colcrys Patient Assistance Program will allow eligible uninsured patients to secure a 90-day supply of Colcrys( )for a $15 co-payment. The program is administered through Rx Outreach, a service provided by Express Scripts Specialty Distribution Services (ESSDS). Patients or physician offices can learn more about eligibility requirements and secure applications online at www.rxoutreach.com or by phone at 1-800-769-3880. The phone line is staffed from 7:00 am - 5:30 pm CST Monday through Friday.

Patients and physicians can also access the Rx Outreach program by visiting www.rxassist.org, www.pparx.org or www.needymeds.org. Preferred or direct clinics may fax their orders to 1-888-430-9818.

Important Safety Information

Colcrys (colchicine, USP) tablets are indicated for the prophylaxis and treatment of acute gout flares and Familial Mediterranean Fever (FMF).

Colcrys is contraindicated in patients with renal or hepatic impairment who are concurrently prescribed P-gp inhibitors or strong inhibitors of CYP3A4 as life-threatening or fatal toxicity has been reported. In a controlled clinical trial, the most common adverse events reported were diarrhea and pharyngolaryngeal pain. Rarely, myelosuppression, thrombocytopenia, and leukopenia have been reported in patients taking colchicine. Rhabdomyolysis has been occasionally observed, especially when colchicine is prescribed in combination with other drugs known to cause this effect. Monitoring is recommended under these conditions.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

You may also report negative side effects to the manufacturer of COLCRYS by calling 1-888-351-3786. Please see www.COLCRYS.com for full prescribing information.

About URL Pharma

URL Pharma, Inc., headquartered in Philadelphia, PA, is a leading specialty pharmaceutical company with fully integrated technology development, product development, manufacturing, and commercialization capabilities. After a long history of generic pharmaceutical research, development, and manufacturing, the Company has successfully transitioned to a technology-driven, specialty pharmaceutical business. The Company seeks to develop and commercialize scientifically and medically innovative products that address unmet medical needs for improvements in safety and efficacy. For more information, visit www.urlpharma.com.

For further information, please call 215-697-1900 or e-mail us at media@urlpharma.com.

SOURCE URL Pharma, Inc.


'/>"/>
SOURCE URL Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. URL Pharma Launches Co-Pay Assistance Program for Colcrys(R)
2. PDI Announces New Pharmaceutical Services Business Win With a Top 5 Pharmaceutical Company
3. National Pharmaceutical Council Welcomes New Member, Otsuka America Pharmaceutical, Inc.
4. CVS/pharmacy to Provide H1N1 Vaccinations in Rhode Island by End of Week
5. Smith & Nephew Completes Acquisition of the Assets of Nucryst Pharmaceuticals Corp.
6. KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010
7. Arena Pharmaceuticals Submits New Drug Application to FDA for Lorcaserin for Weight Management
8. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
9. PDL BioPharma Announces New Licensing Agreement With Eli Lilly
10. Isis Pharmaceuticals to Receive $10 Million From OncoGenex License of OGX-011 to Teva
11. Raptor Pharmaceutical Corp. Announces $7.5 Million Securities Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Analysis 2016 - Forecast to 2022" report to their ... contains up to date financial data derived from varied research ... trends with potential impact on the market during the next ... which comprises of sub markets, regional and country level analysis. ...
(Date:6/23/2016)... , June 23, 2016 , ... on Thursday, July 7, 2016 , , , , LOCATION: ... , , , , EXPERT PANELISTS:  , , , ... Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and ... The global pharmaceutical industry is witnessing an exceptional era. ...
Breaking Medicine Technology:
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... ... Haute Living, is proud to recognize Dr. Barry M. Weintraub as a prominent ... “the most beautiful women in the world, and the most handsome men, look ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):